These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 25901787)
1. CCN5 attenuates profibrotic phenotypes of fibroblasts through the Smad6-CCN2 pathway: Potential role in epidural fibrosis. Xu H; Liu C; Sun Z; Guo X; Zhang Y; Liu M; Li P Int J Mol Med; 2015 Jul; 36(1):123-9. PubMed ID: 25901787 [TBL] [Abstract][Full Text] [Related]
2. CCN2 and CCN5 exerts opposing effect on fibroblast proliferation and transdifferentiation induced by TGF-β. Xu H; Li P; Liu M; Liu C; Sun Z; Guo X; Zhang Y Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1207-19. PubMed ID: 26218313 [TBL] [Abstract][Full Text] [Related]
3. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis. Zhang L; Li Y; Liang C; Yang W Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150 [TBL] [Abstract][Full Text] [Related]
4. [Effects of CCN5 overexpression on the expression of alpha-SMA and collagen I in hepatic stellate cells and its mechanism]. Zhang CY; Xie X; Gao DS; Zhang CX Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 Sep; 29(5):411-5. PubMed ID: 24386815 [TBL] [Abstract][Full Text] [Related]
5. CTGF/CCN2 exerts profibrotic action in myoblasts via the up-regulation of sphingosine kinase-1/S1P3 signaling axis: Implications in the action mechanism of TGFβ. Bruno G; Cencetti F; Pertici I; Japtok L; Bernacchioni C; Donati C; Bruni P Biochim Biophys Acta; 2015 Feb; 1851(2):194-202. PubMed ID: 25457224 [TBL] [Abstract][Full Text] [Related]
6. CCN5 Reduces Ligamentum Flavum Hypertrophy by Modulating the TGF-β Pathway. Ye S; Kwon WK; Bae T; Kim S; Lee JB; Cho TH; Park JY; Kim K; Hur JK; Hur JW J Orthop Res; 2019 Dec; 37(12):2634-2644. PubMed ID: 31334871 [TBL] [Abstract][Full Text] [Related]
7. The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis. Yoon PO; Lee MA; Cha H; Jeong MH; Kim J; Jang SP; Choi BY; Jeong D; Yang DK; Hajjar RJ; Park WJ J Mol Cell Cardiol; 2010 Aug; 49(2):294-303. PubMed ID: 20430035 [TBL] [Abstract][Full Text] [Related]
8. Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts. Mun JH; Kim YM; Kim BS; Kim JH; Kim MB; Ko HC Wound Repair Regen; 2014; 22(1):125-33. PubMed ID: 24471776 [TBL] [Abstract][Full Text] [Related]
9. The carboxyl-terminal TSP1-homology domain is the biologically active effector peptide of matricellular protein CCN5 that counteracts profibrotic CCN2. Zolfaghari S; Kaasbøll OJ; Monsen VT; Sredic B; Hagelin EMV; Attramadal H J Biol Chem; 2023 Jan; 299(1):102803. PubMed ID: 36529291 [TBL] [Abstract][Full Text] [Related]
11. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen. Ponticos M; Holmes AM; Shi-wen X; Leoni P; Khan K; Rajkumar VS; Hoyles RK; Bou-Gharios G; Black CM; Denton CP; Abraham DJ; Leask A; Lindahl GE Arthritis Rheum; 2009 Jul; 60(7):2142-55. PubMed ID: 19565505 [TBL] [Abstract][Full Text] [Related]
12. Single-target RNA interference for the blockade of multiple interacting proinflammatory and profibrotic pathways in cardiac fibroblasts. Tank J; Lindner D; Wang X; Stroux A; Gilke L; Gast M; Zietsch C; Skurk C; Scheibenbogen C; Klingel K; Lassner D; Kühl U; Schultheiss HP; Westermann D; Poller W J Mol Cell Cardiol; 2014 Jan; 66():141-56. PubMed ID: 24239602 [TBL] [Abstract][Full Text] [Related]
13. Role of CCN5 (WNT1 inducible signaling pathway protein 2) in pancreatic islets. Liu JL; Kaddour N; Chowdhury S; Li Q; Gao ZH J Diabetes; 2017 May; 9(5):462-474. PubMed ID: 27863006 [TBL] [Abstract][Full Text] [Related]
14. Substance P increases CCN2 dependent on TGF-beta yet Collagen Type I via TGF-beta1 dependent and independent pathways in tenocytes. Frara N; Fisher PW; Zhao Y; Tarr JT; Amin M; Popoff SN; Barbe MF Connect Tissue Res; 2018 Jan; 59(1):30-44. PubMed ID: 28399671 [TBL] [Abstract][Full Text] [Related]
15. TNF-alpha, but not IFN-gamma, regulates CCN2 (CTGF), collagen type I, and proliferation in mesangial cells: possible roles in the progression of renal fibrosis. Cooker LA; Peterson D; Rambow J; Riser ML; Riser RE; Najmabadi F; Brigstock D; Riser BL Am J Physiol Renal Physiol; 2007 Jul; 293(1):F157-65. PubMed ID: 17376761 [TBL] [Abstract][Full Text] [Related]
16. CCN2 is required for bleomycin-induced skin fibrosis in mice. Liu S; Shi-wen X; Abraham DJ; Leask A Arthritis Rheum; 2011 Jan; 63(1):239-46. PubMed ID: 20936632 [TBL] [Abstract][Full Text] [Related]
17. New role and molecular mechanism of Gadd45a in hepatic fibrosis. Hong L; Sun QF; Xu TY; Wu YH; Zhang H; Fu RQ; Cai FJ; Zhou QQ; Zhou K; Du QW; Zhang D; Xu S; Ding JG World J Gastroenterol; 2016 Mar; 22(9):2779-88. PubMed ID: 26973416 [TBL] [Abstract][Full Text] [Related]
18. Pentoxifylline attenuates tubulointerstitial fibrosis by blocking Smad3/4-activated transcription and profibrogenic effects of connective tissue growth factor. Lin SL; Chen RH; Chen YM; Chiang WC; Lai CF; Wu KD; Tsai TJ J Am Soc Nephrol; 2005 Sep; 16(9):2702-13. PubMed ID: 15987746 [TBL] [Abstract][Full Text] [Related]
19. WISP3 prevents fibroblast-myofibroblast transdifferentiation in NRK-49F cells. Yi Y; Ma J; Jianrao L; Wang H; Zhao Y Biomed Pharmacother; 2018 Mar; 99():306-312. PubMed ID: 29353205 [TBL] [Abstract][Full Text] [Related]
20. The role of ERK and JNK signaling in connective tissue growth factor induced extracellular matrix protein production and scar formation. Hu X; Wang H; Liu J; Fang X; Tao K; Wang Y; Li N; Shi J; Wang Y; Ji P; Cai W; Bai X; Zhu X; Han J; Hu D Arch Dermatol Res; 2013 Jul; 305(5):433-45. PubMed ID: 23494140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]